- Details
- Sigrid Carlsson joins Phillip Koo in a discussion on Smart Screening in Prostate Cancer, a session being highlighted at the upcoming 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer taking place virtually September 22-24. The pair discuss challenges with screening today that require clinicians to be smarter about screening including the risk of overdiagnosis, incorporating...
|
- Details
- Rob Reiter and Alicia Morgans discuss the use of MRI and active surveillance in prostate cancer treatment. Dr. Reiter explains how MRI is used to improve proper patient selection for active surveillance. He also discusses how he was an early adopter of MRI and how he incorporates an MRI-guided biopsy program in his practice. In conclusion, Dr. Reiter and Dr. Morgans agree it’s important to note th...
|
- Details
- Ken Herrmann presents an update on the current data regarding optimal PSMA PET tracers. Biographies: Ken Herrmann, MD, MBA, Professor and Chair of the Department of Nuclear Medicine, Universitatsklinikum Essen, Essen, Germany Related Content: APCCC 2022: Impact of Next Generation Imaging: What Is the Optimal (Current) Tracer for PET-Based Imaging for Staging The Mechanism of PSMA PET for Prostate...
|
- Details
- Wolfgang Fendler and Andrei Gafita join Phillip Koo in a discussion on the Journal of Nuclear Medicine publication "Measuring response in metastatic castration‑resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria". This study received partial funding from the Prostate Cancer Foundation (PCF). In order to move PSMA PET forward and shif...
|
- Details
- Ronaldo Baroni joins Phillip Koo at the 13th Uro-Oncology Congress in São Paulo, Brazil in a discussion highlighting Dr Baroni's lecture he gave on future perspectives in prostate imaging. Prostate MRI is already established as the standard modality for prostate detection prior to biopsy. Future perspectives include more rational and widespread use of prostate MRI including a more widely available...
|
- Details
- Radiation Oncologist, Juan Galvis Serrano joins Phillip Koo for a presentation and discussion on radiotherapy guided by PET PSMA. We are still defining its role in guiding radiotherapy treatment plans but PET-PSMA has shown a higher sensitivity than conventional methods with stable sensitivity and higher specificity. Dr. Galvis Serrano shares a study conducted at his institution with prostate canc...
|
- Details
- Christopher Wallis and Zachary Klaassen highlight the Journal of Nuclear Medicine article titled "PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicenter study." The authors' findings support the new EAU classification for biochemically recurrent prostate cancer (BCR), that BCR high-risk groups have...
|
- Details
- David Schuster joins Phillip Koo in discussing the results of SPOTLIGHT, a phase 3, prospective, multicenter study assessing the detection rate of 18F-rhPSMA-7.3 PET in patients with suspected prostate cancer recurrence. The single-arm SPOTLIGHT imaging study, conducted in the United States and Europe evaluates the safety and diagnostic performance of 18F-rhPSMA-7.3 PET imaging in men with suspect...
|
- Details
- David Penson joins Alicia Morgans to discuss the rapidly changing landscape in prostate cancer, focusing on how imaging and therapeutic advances have disrupted the landscape in the nonmetastatic castration-resistant prostate cancer (CRPC) setting. Dr. Penson highlights advancements in PSMA scanning and how it impacts potential study inclusion criteria. Drs. Morgans and Penson also discuss PSMA PET...
|
- Details
- Phillip Koo is joined by Joseph Osborne to provide a nuclear radiologist's perspective on the equity in prostate cancer clinical trials. Dr. Osborne focuses his talk on three different aspects of clinical trial equity for prostate cancer: Progress, Evolution, and Goals. He also details the Rad Health Equity Lab, created at Weill Cornell to improve access to radiology and bring awareness to health...
|
